AORT Quote, Financials, Valuation and Earnings

Nutriband, Inc. has a net margin of 2.09% compared to Artivion, Inc.'s net margin of -1118.87%. Artivion, Inc.'s return on equity of 2.6% beat Nutriband, Inc.'s return on equity of -164.64%.

Artivion, Inc. has a consensus price target of $51.43, signalling upside risk potential of 37.07%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 275%. Given that Nutriband, Inc. has higher upside potential than Artivion, Inc., analysts believe Nutriband, Inc. is more attractive than Artivion, Inc..

Artivion, Inc. has a beta of 1.591, which suggesting that the stock is 59.114% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.886, suggesting its more volatile than the S&P 500 by 88.601%.

Artivion, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Artivion, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.

Artivion, Inc. quarterly revenues are $116M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. Artivion, Inc.'s net income of $2.4M is higher than Nutriband, Inc.'s net income of -$3.9M. Notably, Artivion, Inc.'s price-to-earnings ratio is 187.79x while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Artivion, Inc. is 3.95x versus 19.96x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

PetVivo Holdings, Inc. has a net margin of 2.09% compared to Artivion, Inc.'s net margin of -765.99%. Artivion, Inc.'s return on equity of 2.6% beat PetVivo Holdings, Inc.'s return on equity of -335.08%.

Artivion, Inc. has a consensus price target of $51.43, signalling upside risk potential of 37.07%. On the other hand PetVivo Holdings, Inc. has an analysts' consensus of -- which suggests that it could grow by 617.88%. Given that PetVivo Holdings, Inc. has higher upside potential than Artivion, Inc., analysts believe PetVivo Holdings, Inc. is more attractive than Artivion, Inc..

Artivion, Inc. has a beta of 1.591, which suggesting that the stock is 59.114% more volatile than S&P 500. In comparison PetVivo Holdings, Inc. has a beta of 0.306, suggesting its less volatile than the S&P 500 by 69.424%.

Artivion, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PetVivo Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Artivion, Inc. pays -- of its earnings as a dividend. PetVivo Holdings, Inc. pays out -- of its earnings as a dividend.

Artivion, Inc. quarterly revenues are $116M, which are larger than PetVivo Holdings, Inc. quarterly revenues of $286.1K. Artivion, Inc.'s net income of $2.4M is higher than PetVivo Holdings, Inc.'s net income of -$2.2M. Notably, Artivion, Inc.'s price-to-earnings ratio is 187.79x while PetVivo Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Artivion, Inc. is 3.95x versus 17.19x for PetVivo Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Pulse Biosciences, Inc. has a net margin of 2.09% compared to Artivion, Inc.'s net margin of -22540.7%. Artivion, Inc.'s return on equity of 2.6% beat Pulse Biosciences, Inc.'s return on equity of -73.32%.

Artivion, Inc. has a consensus price target of $51.43, signalling upside risk potential of 37.07%. On the other hand Pulse Biosciences, Inc. has an analysts' consensus of $26.00 which suggests that it could grow by 2.12%. Given that Artivion, Inc. has higher upside potential than Pulse Biosciences, Inc., analysts believe Artivion, Inc. is more attractive than Pulse Biosciences, Inc..

Artivion, Inc. has a beta of 1.591, which suggesting that the stock is 59.114% more volatile than S&P 500. In comparison Pulse Biosciences, Inc. has a beta of 1.776, suggesting its more volatile than the S&P 500 by 77.577%.

Artivion, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pulse Biosciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Artivion, Inc. pays -- of its earnings as a dividend. Pulse Biosciences, Inc. pays out -- of its earnings as a dividend.

Artivion, Inc. quarterly revenues are $116M, which are larger than Pulse Biosciences, Inc. quarterly revenues of $86K. Artivion, Inc.'s net income of $2.4M is higher than Pulse Biosciences, Inc.'s net income of -$19.4M. Notably, Artivion, Inc.'s price-to-earnings ratio is 187.79x while Pulse Biosciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Artivion, Inc. is 3.95x versus 19,527.45x for Pulse Biosciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Zimmer Biomet Holdings, Inc. has a net margin of 2.09% compared to Artivion, Inc.'s net margin of 6.15%. Artivion, Inc.'s return on equity of 2.6% beat Zimmer Biomet Holdings, Inc.'s return on equity of 5.61%.

Artivion, Inc. has a consensus price target of $51.43, signalling upside risk potential of 37.07%. On the other hand Zimmer Biomet Holdings, Inc. has an analysts' consensus of $102.65 which suggests that it could grow by 4.48%. Given that Artivion, Inc. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe Artivion, Inc. is more attractive than Zimmer Biomet Holdings, Inc..

Artivion, Inc. has a beta of 1.591, which suggesting that the stock is 59.114% more volatile than S&P 500. In comparison Zimmer Biomet Holdings, Inc. has a beta of 0.619, suggesting its less volatile than the S&P 500 by 38.12%.

Artivion, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zimmer Biomet Holdings, Inc. offers a yield of 0.98% to investors and pays a quarterly dividend of $0.24 per share. Artivion, Inc. pays -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc. pays out 27.04% of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Artivion, Inc. quarterly revenues are $116M, which are smaller than Zimmer Biomet Holdings, Inc. quarterly revenues of $2.2B. Artivion, Inc.'s net income of $2.4M is lower than Zimmer Biomet Holdings, Inc.'s net income of $137.9M. Notably, Artivion, Inc.'s price-to-earnings ratio is 187.79x while Zimmer Biomet Holdings, Inc.'s PE ratio is 27.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Artivion, Inc. is 3.95x versus 2.37x for Zimmer Biomet Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.